ORGINAL ARTICLEBiochemical studies on the production of SPARSOMYCIN (cas 1404-64-4) antibiotic by Pseudomonas aeurginosa, AZ-SH-B8 using plastic wastes as fermented substrate
-
Add time:09/03/2019 Source:sciencedirect.com
Hundred and twenty microbial isolates could be isolated from different soil samples collected from different localities in Egypt. One of the bacterial cultures AZ-SH-B8 was found to produce a wide spectrum antimicrobial agent when cultivated on plastic wastes. The bacterial culture AZ-SH-B8 could be isolated from a soil sample collected from Sharkia governorate, Egypt. From the taxonomic features, the bacterial isolate AZ-SH-B8 matches with Pseudomonas aeurginosa in the morphological, physiological and biochemical characters and confirmation by using API20E system. Thus, it was given the suggested name P. aeurginosa, AZ-SH-B8. The parameters controlling the biosynthetic process of antimicrobial agent formation includes: innoculum size, different pH values, different temperatures, different incubation period, different carbon and nitrogen sources and different mineral salts concentrations (KNO3, K2HPO4, MgSO4·7H2O and KCl) were fully investigated. The active metabolite was extracted using n-butanol (1:1, v/v) at pH 7.0. The separation of the active ingredient and its purification was performed using both thin layer chromatography (TLC) and column chromatography (CC) techniques. The physico-chemical characteristics of the purified antibiotic viz. color, melting point, solubility, elemental analysis, spectroscopic characteristics and chemical reactions have been investigated. This analysis indicates a suggested empirical formula of C13H21N3O6S2. The minimum inhibition concentrations “MICs” of the purified antimicrobial agent were also determined. The purified antimicrobial agent was suggestive of belonging to SPARSOMYCIN (cas 1404-64-4) antibiotic produced by P. aeurginosa, AZ-SH-B8.
We also recommend Trading Suppliers and Manufacturers of SPARSOMYCIN (cas 1404-64-4). Pls Click Website Link as below: cas 1404-64-4 suppliers
Prev:DispatchRibosomal translocation: SPARSOMYCIN (cas 1404-64-4) pushes the button
Next:Original paperAntitumour activity and retinotoxicity of ethyldeshydroxy-SPARSOMYCIN (cas 1404-64-4) in mice) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleSynthesis of SPARSOMYCIN (cas 1404-64-4) Analogs as Potential Antitumor Agents09/09/2019
- Synthesis and morphological reversion activity on srctsNRK cells of pyrimidinylpropanamide antibiotics, SPARSOMYCIN (cas 1404-64-4), sparoxomycin A1, A2, and their analogues09/08/2019
- The biosynthesis of SPARSOMYCIN (cas 1404-64-4). Further investigations of the biosynthesis of the uracil acrylic acid moiety09/07/2019
- Structure-activity relationships of SPARSOMYCIN (cas 1404-64-4): modification at the hydroxyl groupRelations structure-activité de la SPARSOMYCIN (cas 1404-64-4)e: modification du groupement hydroxyle09/06/2019
- Potentiation of cisplatin antitumor activity on L1210 leukemia s.c. by SPARSOMYCIN (cas 1404-64-4) and three of its analogues09/05/2019
- Original paperAntitumour activity and retinotoxicity of ethyldeshydroxy-SPARSOMYCIN (cas 1404-64-4) in mice09/04/2019
- DispatchRibosomal translocation: SPARSOMYCIN (cas 1404-64-4) pushes the button09/02/2019
- Genome NoteDraft genome sequence of broad-spectrum antibiotic SPARSOMYCIN (cas 1404-64-4)-producing Streptomyces sparsogenes ATCC 25498 from the American Type Culture Collection09/01/2019


